AFB Q3 2024 Earnings Net Investment Income per Share Reported at 011 No Analyst Estimate Available Soleno Therapeutics Q1 2026 Earnings EPS Misses Estimates by 1494 Stock Holds Steady INVA Q1 2026 Earnings Significant EPS Miss Amid Lack of Revenue Disclosure CLRB Q1 2026 Earnings EPS Surprise Signals Progress Despite PreRevenue Status NATR Q1 2026 Earnings Strong EPS Surprise Amid Quiet Revenue Disclosures NMFCZ Q1 2026 Earnings Missed Estimates by Narrow Margin as EPS Comes in at 032